Initiation of SGLT2 Inhibitors and the Risk of Lower Extremity Minor and Major Amputation in Patients with Type 2 Diabetes and Peripheral Arterial Disease: A Health Claims Data Analysis

2021 ◽  
Author(s):  
Roman N. Rodionov ◽  
Frederik Peters ◽  
Ursula Marschall ◽  
Helmut L’Hoest ◽  
Natalia Jarzebska ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Claims Data ◽  
Arterial Disease ◽  
Major Amputation ◽  
Sglt2 Inhibitors ◽  
Health Claims ◽  
Health Claims Data ◽  
Peripheral Arterial ◽  
Claims Data Analysis

scholarly journals Initiation of insulin therapy in patients with type 2 diabetes: An observational study

2021 ◽  
Vol 72 (1) ◽  
pp. 147-157
Author(s):  
Spela Zerovnik ◽  
Mitja Kos ◽  
Igor Locatelli
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Claims Data ◽  
Health Claims ◽  
Prescribing Patterns ◽  
Insulin Initiation ◽  
Antidiabetic Therapy ◽  
Health Claims Data ◽  
Before And After

Abstract The aim of the study was to assess the initiation of insulin therapy in patients with type 2 diabetes using health claims data on prescription medicines. The study evaluated time to insulin initiation and prescribing patterns of other anti-diabetic medicines before and after insulin initiation. Five years after starting non-insulin antidiabetic therapy, 6.4 % of patients were prescribed insulin, which is substantially lower compared to other similar studies. Among all patients who initiated insulin therapy in 2013, 30 % did not continue any other antidiabetic therapy. However, this proportion was lowered to 20 % in 2018. Before insulin initiation in 2018, metformin was prescribed in only 67 % of patients and sulfonylureas in 78 % of patients. Moreover, metformin and sulfonylureas were discontinued after insulin initiation in 26 and 37 % of patients, resp. More attention should be paid to the continuation of oral anti-diabetics, particularly metformin, after insulin initiation.

scholarly journals The relation of anatomical distribution of symptomatic peripheral arterial disease (PAD) with HbA1c level in patients with type 2 diabetes mellitus

2021 ◽  
Vol 12 ◽  
pp. 204201882110005
Author(s):  
Nawaf J. Shatnawi ◽  
Nabil A. Al-Zoubi ◽  
Hassan M. Hawamdeh ◽  
Yousef S. Khader ◽  
Mowafeq Heis ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Peripheral Arterial Disease ◽  
Hba1c Level ◽  
Arterial Disease ◽  
Anatomical Distribution ◽  
The Mean ◽  
Peripheral Arterial

Aims: Increased level of glycated hemoglobin (HbA1c) is associated with an increased prevalence of peripheral arterial disease (PAD). This study aimed to assess the relationship between the anatomical distribution of symptomatic PAD lesions in patients with type 2 diabetes and HbA1c levels at the time of PAD diagnosis. Patients and methods: A retrospective study was conducted at King Abdullah University Hospital during the period August 2011 to December 2015. Consecutive patients with type 2 diabetes presented with symptomatic PAD confirmed by computed tomography-angiography (CTA) were included in this study. CTA images were reviewed. Relevant information including demographic data, PAD symptoms, comorbidities, HbA1c level, lipid profile, C-reactive protein and the mean platelets volume were retrieved from medical records. Results: A total of 332 patients with type 2 diabetes (255 males and 77 females) were included in this study. The mean HbA1c at the time of PAD diagnosis was 8.68% (±2.06%). The prevalence of hemodynamic relevant atherosclerotic lesions of the superficial femoral artery, popliteal artery, leg vessels, femoro-popliteal, and crural segments was significantly higher in patients with HbA1c >7.5% compared with patients with HbA1c ⩽7.5%. Conclusion: The anatomical distribution of symptomatic PAD in patients with type 2 diabetes mellitus differed significantly according to HbA1c level at the time of PAD diagnosis.

P 2: CRP as a possible predictor for peripheral arterial disease in patients with type 2 diabetes

2012 ◽  
Vol 38 ◽  
pp. S103-S104
Author(s):  
Lj. Popovic ◽  
K. Lalic ◽  
D. Draskovic Radojkovic ◽  
N. Rajkovic ◽  
S. Singh ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Peripheral Arterial Disease ◽  
Arterial Disease ◽  
Peripheral Arterial

Lanarkshire Oximetry Index as a Diagnostic Tool for Peripheral Arterial Disease in Type 2 Diabetes: A Pilot Study

Angiology ◽  
2010 ◽  
Vol 61 (4) ◽  
pp. 388-391 ◽  
Author(s):  
N. Papanas ◽  
D. Kakagia ◽  
K. Papatheodorou ◽  
D. Papazoglou ◽  
M. Alexandridou ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pilot Study ◽  
Peripheral Arterial Disease ◽  
Diagnostic Tool ◽  
Arterial Disease ◽  
Peripheral Arterial

scholarly journals Prevalence of peripheral arterial disease and associated factors in people with type 2 diabetes

2021 ◽  
Vol 34 ◽  
Author(s):  
Pedro José da Silva Filho ◽  
Elaine Cristina Martinez Teodoro ◽  
Elaine Cristina Alves Pereira ◽  
Vania Cristina dos Reis Miranda
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Physical Inactivity ◽  
Associated Factors ◽  
Family Health ◽  
Arterial Disease ◽  
The Family ◽  
Peripheral Arterial

Abstract Introduction: The high rate of diabetes mellitus index (DM), along with the increase in cardiovascular compromise that DM favors, and the scarcity of epidemiological data regarding the prevalence of peripheral arterial disease (PAD) in this population, make it important to study risk factors associated with the development of PAD in the population with type 2 diabetes mellitus (DM2). Objective: To estimate the prevalence of PAD together with the associated factors in a sample of patients with DM2, treated in the Family Health Strategies (FHS) program, in the municipality of Pindamonhangaba, SP. Methods: Quantitative research in a cross-sectional study of 38 individuals who were diagnosed with DM2, between 40 and 77 years old, selected by convenience sampling and treated in the family health program in two different districts of the municipality. The method consisted of the evaluation of personal and anthropometric data, anamnesis and physical examination including the ankle-brachial index (ABI). Results: PAD was present in 21.1% (95%CI: 16.9 to 25.8) of the investigated population. Risk factors observed were age range of 51 to 69 years (75%), overweight (50%), systemic arterial hypertension (SAH) (100%), smoking (62.5%) and physical inactivity (87.5%). Conclusion: The prevalence of PAD was more than a fifth of those diagnosed with DM2, and the most prevalent associated risk factors were SAH, physical inactivity, smoking and overweight with and without PAD.

Sign in / Sign up

Export Citation Format

Share Document